The business impact
2 major sections of the CSR covered for phase 1 and 3 in three therapeutic areas
Writing time reduced by 1/3 on these sections
Employees could focus on more high-value, scientific sections of the report
The business challenge
Sanofi, a multinational pharmaceutical company, was looking to reduce the time it takes to get drugs to market by streamlining its CSR report generation process. As complex and heavily regulated reports, they needed to be 100% accurate and fully traceable for compliance purposes.
The NLG solution
Yseop worked in full collaboration with Sanofi’s Medical Writers to learn their practices and co-build a sophisticated medical writer assistant powered by NLG. The solution was a human-in-control intelligent automation system for automatic writing, which produced draft sections of CSR text for review. The system is able to mine clinical data for complex, rule-based analysis.
With this solution, Sanofi is able today to automate two major sections of the CSR covered for phase 1 and 3 clinical studies in three therapeutic areas: pharma, oncology and vaccine. This resulted in writing time being reduced by 30% on these sections, meaning employees could focus on more high-value, scientific sections of the report.
Ultimately for Sanofi this has meant saving time for the delivery of the study reports.